SavedAdd your journal

Journals / Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi / 2019 / Cilt: 16 - Sayı: 2

Evaluation Of Renin Angiotensin Aldosteron System With Plasma Renin Activity In Polycystic Ovarian Syndrome

Polikistik Over Sendromunda Renin Anjiotensin Aldosteron Sisteminin Plazma Renin Aktivitesi ile Değerlendirilmesi

Üçler KISA
Özlem Banu TULMAÇ
Pages
60–63
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In brief, PRA levels increase significantly in PCOS, which indicates an activity in the RAS in PCOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The present study intends to investigate the relationship between polycystic ovarian syndrome PCOS and renin anjiotensin aldosteron system RAS .Material and Methods: It is a prospective cross-sectional study conducted at Gynecology Clinic of Faculty of Medicine in Kirikkale University.
📊
Key Findings & Data:The study group consists of a total of 126 patients, aged between 18 and 40. 96 were diagnosed with PCOS, and 30 were non-PCOS patients control group .
💡
Conclusion & Impact:In brief, PRA levels increase significantly in PCOS, which indicates an activity in the RAS in PCOS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Polikistik over sendromu · plazma renin aktivitesi · renin anjiotensin aldosteron sistemi

Abstract

Aim: The present study intends to investigate the relationship between polycystic ovarian syndrome PCOS and renin anjiotensin aldosteron system RAS .Material and Methods: It is a prospective cross-sectional study conducted at Gynecology Clinic of Faculty of Medicine in Kirikkale University. The study group consists of a total of 126 patients, aged between 18 and 40. 96 were diagnosed with PCOS, and 30 were non-PCOS patients control group . All the patients were given a fasting blood test in the morning, and the plasma renin activity PRA was assessed. Statistical analyses were performed to see the difference between the groups.Conclusion: PRA was 287 10-693 pg/ml and 213 50-802 pg/ml in PCOS and non-PCOS group, respectively. Statistically significant difference was identified between the groups p:0.048 . In brief, PRA levels increase significantly in PCOS, which indicates an activity in the RAS in PCOS.

Özet

Amaç: Polikistik over sendromu PKOS ile renin anjiotensin aldosteron RAS sisteminin ilişkisini araştırmaktır.Gereç ve Yöntemler: Çalışma Kırıkkale Üniversitesi Tıp Fakültesi Jinekoloji polikliniğine başvuran, 18-40 yaş arası, 96 PKOS tanısı alan hasta ile, 30 PKOS olmayan sağlıklı kontrol hastası toplam 126 hastanın dahil edildiği, prospektif kesitsel bir çalışmadır. Tüm hastalara sabah aç ve ayakta alınan kan örneklerinde plazma renin aktivitesi PRA çalışıldı. Gruplar arasında PRA açısından istatistiksel anlamlı bir farkın olup olmadığı değerlendirildi.Sonuç: PKOS tanısı alan hasta grubunda PRA 287 10-693 pg/ml, kontrol grubunda PRA 213 50-802 pg/ml tespit edildi. Sonuçta PKOS da PRA düzeylerinde anlamlı bir artış saptanmaktadır p=0,048 Bu artış PKOS da RAS sisteminde bir aktivasyona işaret etmektedir.

🔖

Cite This Article

KISA, Ü., TULMAÇ, Ö. B. (2022). Evaluation Of Renin Angiotensin Aldosteron System With Plasma Renin Activity In Polycystic Ovarian Syndrome. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 16 - Sayı: 2, 60–63. https://ajindex.com/articles/558656

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics and gynecology. 2018;131(6):e157-e71. Dunaif A. Insulin resistance and the polycystic ovary syndrome: me- chanism and implications for pathogenesis. Endocrine reviews. 1997;18(6):774-800.
  2. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism. 2006;91(1):48-53.
  3. Manrique C, Lastra G, Gardner M, Sowers JR. The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative Stress. Medical Clinics of North America. 2009;93(3):569-82.
  4. Palumbo A, Jones C, Lightman A, Carcangiu ML, DeCherney AH, Naftolin F. Immunohistochemical localization of renin and angiotensin II in human ovaries. American journal of obstetrics and gynecology. 1989;160(1):8- 14. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, et al. An- giotensin receptors in the nervous system. Brain research bulletin. 1998;47(1):17-28. Kalenga MK, de Gasparo M, Thomas K, de Hertogh R. Angiotensin II and its different receptor subtypes in placenta and fetal membranes. Placenta. 1996;17(2-3):103-10. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. The Journal of physiology. 2007;580(Pt 1):31-7. Palumbo A, Ávila J, Naftolin F. The Ovarian Renin–Angiotensin System (OVRAS). Reproductive Sciences. 2016;23(12):1644-55.
  5. Palumbo A, Pourmotabbed G, Carcangiu ML, Andrade-Gordon P, Roa L, DeCherney A, et al. Immunohistochemical localization of renin and angi- otensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertility and sterility. 1993;60(2):280-4.
  6. Palumbo A, Carcangiu ML, Roa L, Pepperell J, Pourmotabbed G, Naftolin F. The ovarian renin-angiotensin system in polycystic ovarian syndrome. Annals of the New York Academy of Sciences. 1993;687:39-45.
  7. Uncu G, Sözer MC, Develioğlu O, Cengiz C. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS. Gynecological Endocrino- logy. 2009;16(6):447-52.
  8. Armanini D, Bordin L, Donà G, Sabbadin C, Bakdounes L, Ragazzi E, et al. Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids. 2012;77(6):655-8. Revised 2003 consensus on diagnostic criteria and long-term healt